HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Human African trypanosomiasis: diagnosis, relapse and survival after severe melarsoprol-induced encephalopathy.

Abstract
We describe a case of human African trypanosomiasis with a number of unusual features. The clinical presentation was subacute, but the infection was shown to be due to Trypanosoma brucei rhodesiense. The infection relapsed twice following treatment and the patient developed a melarsoprol-associated encephalopathy. Magnetic resonance imaging (MRI) findings were suggestive of microhaemorrhages, well described in autopsy studies of encephalopathy but never before shown on MRI. The patient survived severe encephalopathy with a locked-in syndrome. Our decision to provide ongoing life support may be useful to physicians treating similar cases in a setting where intensive care facilities are available.
AuthorsA M Checkley, J Pepin, W C Gibson, M N Taylor, H R Jäger, D C Mabey
JournalTransactions of the Royal Society of Tropical Medicine and Hygiene (Trans R Soc Trop Med Hyg) Vol. 101 Issue 5 Pg. 523-6 (May 2007) ISSN: 0035-9203 [Print] England
PMID17270227 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Trypanocidal Agents
  • Melarsoprol
Topics
  • Adult
  • Animals
  • Brain Diseases (chemically induced, diagnosis)
  • Humans
  • Magnetic Resonance Imaging
  • Male
  • Melarsoprol (adverse effects, therapeutic use)
  • Polymerase Chain Reaction (methods)
  • Recurrence
  • Trypanocidal Agents (adverse effects, therapeutic use)
  • Trypanosoma brucei rhodesiense (classification)
  • Trypanosomiasis, African (diagnosis, drug therapy, mortality)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: